Key immune related genes and potential therapeutic targets in immune checkpoint inhibitor associated myocarditis: a new fing

29 August 2025 (14:30 - 14:40)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Junyi Zhang

The Fourth Affiliated Hospital of Soochow University, Suzhou (China)

5 More presentations in this session

Presentation thumbnail

Efficacy and safety of prolonged edoxaban treatment for gastrointestinal cancer patients with isolated distal deep vein thrombosis: insight from the ONCO DVT study

Doctor Y. Yamashita (Kyoto, JP)

Abstract Slides Video

Presentation thumbnail

Predictive factors and baseline risk stratification for CAR-T cell therapy-related cardiovascular toxicity

Professor D. Farmakis (Athens, GR)

Abstract Slides Video

Presentation thumbnail

Cardiovascular disease is a significant contributor to the incidence of cancer, second-primary cancer, and cancer-related hospitalization

Mr T. Caller (Tel Aviv, IL)

Abstract Slides Video

Presentation thumbnail

A novel machine learning-based adverse cardiovascular events risk score for cancer patients treated with immune checkpoint inhibitors

Mr J. Cross (New Haven, US)

Abstract Slides Video

Presentation thumbnail

Myocardial fibrosis identification in patients with anthracycline-induced cardiotoxicity: a biomarkers and cardiac magnetic resonance correlation

Doctor R. Maragna (Milan, IT)

Abstract Slides Video

Access the full session

Session thumbnail

Refining risk scores in cardio-oncology

The Event

Event poster

ESC Congress 2025

29 August 2025 14:30 CET

You may be interested in

Congress Presentation

Immune checkpoint inhibitor myocarditis

Congress Presentation

Check-point inhibition: cardiovascular consequences and their prevention

Congress Presentation

Immune checkpoint inhibition and cardiovascular toxicity

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources